TRIGGER
The Twice-Monthly Electronic Newsletter on the Biology of Tissue Factor, Factor VII and TFPI
Vol. 17, No. 18 September 15, 2011
__________________________________________________________
TRIGGER is also available by RSS Feed:
and BLOG:
http://trigger-tf7.blogspot.com/
__________________________________________________________
DISCLAIMER: Commercial product announcements appearing in TRIGGER are provided "as is" for informational purposes only. The editors of TRIGGER have not necessarily evaluated any materials from commercial suppliers described in this newsletter or on its web sites, and we certainly are not endorsing any specific suppliers or products. Furthermore, the editors receive no revenues from any source in the course of publishing TRIGGER.
__________________________________________________________
PAPERS IN PRESS
None submitted for this issue.
__________________________________________________________
RECENT PUBLICATIONS ON TISSUE FACTOR, FACTOR VII, AND TFPI
Hayanga AJ (2011) Off-Label Use of Recombinant Factor VIIa. Ann Intern Med 155:337-338.
http://www.ncbi.nlm.nih.gov/pubmed/21893632
Hong-Xia W, Xiu-Mei L, Xiu-Hua H, Ya-Jun J, Gui-Hua Z, Wan-Chuan Z (2011) Clinical Significance of Tissue Factor and Vascular Endothelial Growth Factor Expressions on CD14+ Monocytes in Patients with Non Hodgkin Lymphoma. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 33:427-431.
http://www.ncbi.nlm.nih.gov/pubmed/21906453
Huang XX, Pang BS, Yang YH, Zhang HY, Guo SL (2011) [Change of coagulation functions and its significance in acute exacerbation of chronic obstructive pulmonary disease]. Zhonghua Yi Xue Za Zhi 91:1543-1545.
http://www.ncbi.nlm.nih.gov/pubmed/21914367
Ingerslev J, Sorensen B (2011) Parallel use of by-passing agents in haemophilia with inhibitors: a critical review. Br J Haematol.
http://www.ncbi.nlm.nih.gov/pubmed/21895627
Jenabali Jahromi B, Karimi M (2011) Long-term follow-up of prophylaxis with recombinant activated factor VII in patients with congenital factor VII deficiency. Haemophilia 17:713-715.
http://www.ncbi.nlm.nih.gov/pubmed/21299748
Jiang M, Wang Z, Yu Z, Bai X, Su J, Cao L, . . . Ruan C (2011) A novel missense mutation close to the charge-stabilizing system in a patient with congenital factor VII deficiency. Blood Coagul Fibrinolysis 22:264-270.
http://www.ncbi.nlm.nih.gov/pubmed/21372693
Jiang R, Wang NP, Tanaka KA, Levy JH, Guyton RA, Zhao ZQ, Vinten-Johansen J (2011) Factor Xa induces tissue factor expression in endothelial cells by P44/42 MAPK and NF-kappaB-dependent pathways. J Surg Res 169:319-327.
http://www.ncbi.nlm.nih.gov/pubmed/20451919
Kassel KM, Owens Iii AP, Rockwell CE, Sullivan BP, Wang R, Tawfik O, . . . Luyendyk JP (2011) Protease-Activated Receptor 1 and Hematopoietic Cell Tissue Factor Are Required for Hepatic Steatosis in Mice Fed a High-Fat Diet. Am J Pathol.
http://www.ncbi.nlm.nih.gov/pubmed/21907177
Kostovski E, Dahm AE, Iversen N, Hjeltnes N, Osterud B, Sandset PM, Iversen PO (2011) Melatonin stimulates release of tissue factor pathway inhibitor from the vascular endothelium. Blood Coagul Fibrinolysis 22:254-259.
http://www.ncbi.nlm.nih.gov/pubmed/21297449
Kresge N, Simoni RD, Hill RL (2011) Blood clotting and coagulation factors: the work of Yale Nemerson. 1980, 1982. J Biol Chem 286:e5-6.
http://www.ncbi.nlm.nih.gov/pubmed/21842549
Layland J, Ray MJ, Siresena T, Walters DL (2011) Increased expression of monocyte tissue factor and soluble CD40 ligand at mid-term follow-up following percutaneous coronary intervention. Blood Coagul Fibrinolysis 22:349-350.
http://www.ncbi.nlm.nih.gov/pubmed/21546798
Liu Y, Jiang P, Capkova K, Xue D, Ye L, Sinha SC, . . . Liu C (2011) Tissue Factor Activated Coagulation Cascade in The Tumor Microenvironment Is Critical For Tumor Progression And an Effective Target For Therapy. Cancer Res.
http://www.ncbi.nlm.nih.gov/pubmed/21880589
Masotti L, Di Napoli M, Godoy DA, Rafanelli D, Liumbruno G, Koumpouros N, . . . Prisco D (2011) The practical management of intracerebral hemorrhage associated with oral anticoagulant therapy. Int J Stroke 6:228-240.
http://www.ncbi.nlm.nih.gov/pubmed/21557810
Mirzaahmadi S, Asaadi-Tehrani G, Bandehpour M, Davoudi N, Tahmasbi L, Hosseinzadeh N, . . . Kazemi B (2011) Expression of Recombinant Human Coagulation Factor VII by the Lizard Leishmania Expression System. J Biomed Biotechnol 2011:873874.
http://www.ncbi.nlm.nih.gov/pubmed/21912483
Neufeld EJ, Kessler CM, Gill JC, Wilke CT, Cooper DL (2011) Exposure and safety of higher doses of recombinant factor VIIa >/=250 mug kg(-1) in individuals with congenital haemophilia complicated by alloantibody inhibitors: the Haemophilia and Thrombosis Research Society Registry experience (2004-2008). Haemophilia 17:650-656.
http://www.ncbi.nlm.nih.gov/pubmed/21299750
Newell-Caito JL, Laha M, Tharp AC, Creamer JI, Xu H, Maddur AA, . . . Bock PE (2011) Notecarin D binds human factor V and factor Va with high affinity in the absence of membranes. J Biol Chem.
http://www.ncbi.nlm.nih.gov/pubmed/21911491
Ogiwara K, Nogami K, Shima M (2011) Factor VIII activation by factor VIIa analog V158D/E296V/M298Q) in tissue factor-independent mechanisms. Thromb Haemost 106.
http://www.ncbi.nlm.nih.gov/pubmed/21901232
Phillips A (2011) Off-Label Use of Recombinant Factor VIIa. Ann Intern Med 155:337.
http://www.ncbi.nlm.nih.gov/pubmed/21893633
Piek CJ, Brinkhof B, Teske E, Rothuizen J, Dekker A, Penning LC (2011) High intravascular tissue factor expression in dogs with idiopathic immune-mediated haemolytic anaemia. Vet Immunol Immunopathol.
http://www.ncbi.nlm.nih.gov/pubmed/21899896
Sen P, Nayak R, Clark CA, Gopalakrishnan R, Esmon CT, Pendurthi UR, Rao LV (2011) Factor X binding to endothelial cell protein C receptor: comparison with factor VIIa and activated protein C. Blood 118:2635-2636.
http://www.ncbi.nlm.nih.gov/pubmed/21885613
Steiner T, Vincent C, Morris S, Davis S, Vallejo-Torres L, Christensen MC (2011) Neurosurgical outcomes after intracerebral hemorrhage: results of the Factor Seven for Acute Hemorrhagic Stroke Trial (FAST). J Stroke Cerebrovasc Dis 20:287-294.
http://www.ncbi.nlm.nih.gov/pubmed/20452785
Tiede A, Rand JH, Budde U, Ganser A, Federici AB (2011) How I treat the acquired von Willebrand syndrome. Blood 117:6777-6785.
http://www.ncbi.nlm.nih.gov/pubmed/21540459
Tong Y, Zhou J, Mao M, Gao J, Yuan L (2011) Generation of bioactive recombinant Ancylostoma caninum anticoagulant peptide c2. Protein Expr Purif.
http://www.ncbi.nlm.nih.gov/pubmed/21907287
Valentino LA, Cooper DL, Goldstein B (2011) Surgical experience with rFVIIa (NovoSeven) in congenital haemophilia A and B patients with inhibitors to factors VIII or IX. Haemophilia 17:579-589.
http://www.ncbi.nlm.nih.gov/pubmed/21294815
van den Berg YW, Reitsma PH (2011) Not Exclusively Tissue Factor: NETs Provide Another Link Between Chemotherapy and Thrombosis. J Thromb Haemost.
http://www.ncbi.nlm.nih.gov/pubmed/21910822
Van Dreden P, Woodhams B, Rousseau A, Favier M, Favier R (2011) Comparative evaluation of Tissue factor and Thrombomodulin activity changes during normal and idiopathic early and late foetal loss: The cause of hypercoagulability? Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/21880353
Winckers K, Siegerink B, Duckers C, Maurissen LM, Tans G, Castoldi E, . . . Rosendaal FR (2011) Increased Tissue Factor Pathway Inhibitor Activity is Associated with Myocardial Infarction in Young Women; Results From the Ratio Study. J Thromb Haemost.
http://www.ncbi.nlm.nih.gov/pubmed/21895962
Xu G, Wen H, Zhou H, Guo D, Zhou F, Chen D, . . . Wang H (2011) Involvement of IRAKs and TRAFs in anti-beta2GPI/ beta2GPI-induced tissue factor expression in THP-1 cells. Thromb Haemost 106.
http://www.ncbi.nlm.nih.gov/pubmed/21901230
Xu GY, Zhou H, Wen HP, Guo DL, Zhou F, Chen DD, Xie HX (2011) [Activation of tumor necrosis factor receptor-associated factor 6 in anti-beta2GPI/beta2GPI-induced tissue factor expression on THP-1 cells]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 27:487-490.
http://www.ncbi.nlm.nih.gov/pubmed/21557901
__________________________________________________________ABOUT TRIGGER
TRIGGER is edited by Jim Morrissey and Pierre Neuenschwander, with editorial assistance by Genie Morrissey. It includes Abstracts of Papers in Press, Meeting Announcements, Positions Sought/Available,or any other pertinent item that subscribers may want to share with their colleagues. To submit an item for publication in Trigger, e-mail us. To request or cancel a subscription,or for more information about TRIGGER or the biology of tissue factor and factor VII, visit our web site. You can also contact us by mail: J.H. Morrissey, University of Illinois College of Medicine, 417 Med Sci Bldg MC-714, 506 S. Mathews Ave., Urbana, IL 61801, USA.
DISCLAIMER: TRIGGER is provided "as is" for information purposes only and without warranty of any kind, express or implied. Users shall assume the entire risk as to the accuracy and usefulness of information in TRIGGER. Opinions expressed here are not necessarily those of the editors or their employers. You may share TRIGGER with your scientific colleagues but you are not permitted to use it or its contents for commercial purposes.
__________________________________________________________
The Twice-Monthly Electronic Newsletter on the Biology of Tissue Factor, Factor VII and TFPI
Vol. 17, No. 18 September 15, 2011
(The next issue will be on October 3, 2011)
TRIGGER is also available by RSS Feed:
and BLOG:
http://trigger-tf7.blogspot.com/
__________________________________________________________
PRODUCT ANNOUNCEMENT
Haematologic Technologies, Inc. supplies a full range of purified proteins and antibodies for use in thrombosis research. These proteins include:
- Purified human factor VIIa - purified from human plasma, and greater than 95% pure by SDS-PAGE. Anti-VIIa is also available. http://www.haemtech.com/Enzymes/Factor_VIIa.htm
- Recombinant human Tissue Factor - Fully functional, purified recombinant (Baculovirus) full -length Tissue factor. Anti-TF is also available. http://www.haemtech.com/Other/TissueFactor.htm
- Corn Trypsin Inhibitor - for use in thrombin generation assays and for the study of TF-dependent pathway of coagulation. http://www.haemtech.com/Inhibitors_Substrates/CTI.htm
DISCLAIMER: Commercial product announcements appearing in TRIGGER are provided "as is" for informational purposes only. The editors of TRIGGER have not necessarily evaluated any materials from commercial suppliers described in this newsletter or on its web sites, and we certainly are not endorsing any specific suppliers or products. Furthermore, the editors receive no revenues from any source in the course of publishing TRIGGER.
__________________________________________________________
PAPERS IN PRESS
None submitted for this issue.
__________________________________________________________
RECENT PUBLICATIONS ON TISSUE FACTOR, FACTOR VII, AND TFPI
Papers are culled from NLM MedLine (PubMed). Titles in square brackets indicate that the paper was not published in English. References that lack volume or page numbers are typically electronic pre-publications (E-pubs) ahead of the print publication; if so, the final citation with volume and page numbers may or may not appear in a future issue of Trigger.
THE FOLLOWING LINK WILL TAKE YOU TO THE ENTIRE LIST OF THIS ISSUE'S PUBLICATIONS IN A PUBMED "COLLECTION":
http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/public/1pWlfra1u7gGhm5MJnG6GUl/
Abdel-Bakky MS, Hammad MA, Walker LA, Ashfaq MK (2011) Tissue factor dependent liver injury causes release of retinoid receptors (RXR-alpha and RAR-alpha) as lipid droplets. Biochem Biophys Res Commun 410:146-151.
http://www.ncbi.nlm.nih.gov/pubmed/21658367
Agar C, de Groot PG, Morgelin M, Monk SD, van Os G, Levels JH, . . . Meijers JC (2011) beta-glycoprotein I: a novel component of innate immunity. Blood 117:6939-6947.
http://www.ncbi.nlm.nih.gov/pubmed/21454452
Aleman MM, Gardiner C, Harrison P, Wolberg AS (2011) Differential Contributions of Monocyte- and Platelet-derived Microparticles towards Thrombin Generation and Fibrin Formation and Stability. J Thromb Haemost.
http://www.ncbi.nlm.nih.gov/pubmed/21883880
Bastarache JA, Sebag SC, Grove BS, Ware LB (2011) Interferon-gamma and tumor necrosis factor-alpha act synergistically to up-regulate tissue factor in alveolar epithelial cells. Exp Lung Res 37:509-517.
http://www.ncbi.nlm.nih.gov/pubmed/21913843
Blatny J, Seidlova D, Penka M, Ovesna P, Brabec P, Sevcik P, . . . Cerny V (2011) Severe postpartum haemorrhage treated with recombinant activated Factor VII in 80 Czech patients: analysis of the UniSeven registry. Int J Obstet Anesth.
http://www.ncbi.nlm.nih.gov/pubmed/21907559
Chen Z, Huo JR, Yang L, Zhu HY (2011) Effect of ligustrazine on mice model of hepatic veno-occlusive disease induced by Gynura segetum. J Gastroenterol Hepatol 26:1016-1021.
http://www.ncbi.nlm.nih.gov/pubmed/21251065
Cimmino G, D'Amico C, Vaccaro V, D'Anna M, Golino P (2011) The missing link between atherosclerosis, inflammation and thrombosis: is it tissue factor? Expert Rev Cardiovasc Ther 9:517-523.
http://www.ncbi.nlm.nih.gov/pubmed/21517734
Colace TV, Jobson J, Diamond SL (2011) Relipidated Tissue Factor Linked to Collagen Surfaces Potentiates Platelet Adhesion and Fibrin Formation in a Microfluidic Model of Vessel Injury. Bioconjug Chem.
http://www.ncbi.nlm.nih.gov/pubmed/21902184
Delluc A, Rousseau A, Delluc C, Le Moigne E, Le Gal G, Mottier D, . . . Lacut K (2011) Venous thromboembolism in patients with pancreatic cancer: implications of circulating tissue factor. Blood Coagul Fibrinolysis 22:295-300.
http://www.ncbi.nlm.nih.gov/pubmed/21372691
Egorina EM, Sovershaev MA, Bogdanov VY, Sovershaev TA, Fallon JT, Seredkina N, . . . Hansen JB (2011) Low thrombogenicity of calcified atherosclerotic plaques is associated with bone morphogenetic protein-2-dependent inhibition of tissue factor expression. Blood Coagul Fibrinolysis.
http://www.ncbi.nlm.nih.gov/pubmed/21897206
Ganetsky M, Babu KM, Salhanick SD, Brown RS, Boyer EW (2011) Dabigatran: Review of Pharmacology and Management of Bleeding Complications of This Novel Oral Anticoagulant. J Med Toxicol.
http://www.ncbi.nlm.nih.gov/pubmed/21887485
Girolami A, Bertozzi I, de Marinis GB, Bonamigo E, Fabris F (2011) Activated FVII levels in factor VII Padua (Arg304Gln) coagulation disorder and in true factor VII deficiency: a study in homozygotes and heterozygotes. Hematology 16:308-312.
http://www.ncbi.nlm.nih.gov/pubmed/21902896
Gringeri A, Fischer K, Karafoulidou A, Klamroth R, Lopez-Fernandez MF, Mancuso E (2011) Sequential combined bypassing therapy is safe and effective in the treatment of unresponsive bleeding in adults and children with haemophilia and inhibitors. Haemophilia 17:630-635.
http://www.ncbi.nlm.nih.gov/pubmed/21323801
Han CS, Schatz F, Lockwood CJ (2011) Abruption-associated prematurity. Clin Perinatol 38:407-421.
http://www.ncbi.nlm.nih.gov/pubmed/21890016
http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/public/1pWlfra1u7gGhm5MJnG6GUl/
Abdel-Bakky MS, Hammad MA, Walker LA, Ashfaq MK (2011) Tissue factor dependent liver injury causes release of retinoid receptors (RXR-alpha and RAR-alpha) as lipid droplets. Biochem Biophys Res Commun 410:146-151.
http://www.ncbi.nlm.nih.gov/pubmed/21658367
Agar C, de Groot PG, Morgelin M, Monk SD, van Os G, Levels JH, . . . Meijers JC (2011) beta-glycoprotein I: a novel component of innate immunity. Blood 117:6939-6947.
http://www.ncbi.nlm.nih.gov/pubmed/21454452
Aleman MM, Gardiner C, Harrison P, Wolberg AS (2011) Differential Contributions of Monocyte- and Platelet-derived Microparticles towards Thrombin Generation and Fibrin Formation and Stability. J Thromb Haemost.
http://www.ncbi.nlm.nih.gov/pubmed/21883880
Bastarache JA, Sebag SC, Grove BS, Ware LB (2011) Interferon-gamma and tumor necrosis factor-alpha act synergistically to up-regulate tissue factor in alveolar epithelial cells. Exp Lung Res 37:509-517.
http://www.ncbi.nlm.nih.gov/pubmed/21913843
Blatny J, Seidlova D, Penka M, Ovesna P, Brabec P, Sevcik P, . . . Cerny V (2011) Severe postpartum haemorrhage treated with recombinant activated Factor VII in 80 Czech patients: analysis of the UniSeven registry. Int J Obstet Anesth.
http://www.ncbi.nlm.nih.gov/pubmed/21907559
Chen Z, Huo JR, Yang L, Zhu HY (2011) Effect of ligustrazine on mice model of hepatic veno-occlusive disease induced by Gynura segetum. J Gastroenterol Hepatol 26:1016-1021.
http://www.ncbi.nlm.nih.gov/pubmed/21251065
Cimmino G, D'Amico C, Vaccaro V, D'Anna M, Golino P (2011) The missing link between atherosclerosis, inflammation and thrombosis: is it tissue factor? Expert Rev Cardiovasc Ther 9:517-523.
http://www.ncbi.nlm.nih.gov/pubmed/21517734
Colace TV, Jobson J, Diamond SL (2011) Relipidated Tissue Factor Linked to Collagen Surfaces Potentiates Platelet Adhesion and Fibrin Formation in a Microfluidic Model of Vessel Injury. Bioconjug Chem.
http://www.ncbi.nlm.nih.gov/pubmed/21902184
Delluc A, Rousseau A, Delluc C, Le Moigne E, Le Gal G, Mottier D, . . . Lacut K (2011) Venous thromboembolism in patients with pancreatic cancer: implications of circulating tissue factor. Blood Coagul Fibrinolysis 22:295-300.
http://www.ncbi.nlm.nih.gov/pubmed/21372691
Egorina EM, Sovershaev MA, Bogdanov VY, Sovershaev TA, Fallon JT, Seredkina N, . . . Hansen JB (2011) Low thrombogenicity of calcified atherosclerotic plaques is associated with bone morphogenetic protein-2-dependent inhibition of tissue factor expression. Blood Coagul Fibrinolysis.
http://www.ncbi.nlm.nih.gov/pubmed/21897206
Ganetsky M, Babu KM, Salhanick SD, Brown RS, Boyer EW (2011) Dabigatran: Review of Pharmacology and Management of Bleeding Complications of This Novel Oral Anticoagulant. J Med Toxicol.
http://www.ncbi.nlm.nih.gov/pubmed/21887485
Girolami A, Bertozzi I, de Marinis GB, Bonamigo E, Fabris F (2011) Activated FVII levels in factor VII Padua (Arg304Gln) coagulation disorder and in true factor VII deficiency: a study in homozygotes and heterozygotes. Hematology 16:308-312.
http://www.ncbi.nlm.nih.gov/pubmed/21902896
Gringeri A, Fischer K, Karafoulidou A, Klamroth R, Lopez-Fernandez MF, Mancuso E (2011) Sequential combined bypassing therapy is safe and effective in the treatment of unresponsive bleeding in adults and children with haemophilia and inhibitors. Haemophilia 17:630-635.
http://www.ncbi.nlm.nih.gov/pubmed/21323801
Han CS, Schatz F, Lockwood CJ (2011) Abruption-associated prematurity. Clin Perinatol 38:407-421.
http://www.ncbi.nlm.nih.gov/pubmed/21890016
Hayanga AJ (2011) Off-Label Use of Recombinant Factor VIIa. Ann Intern Med 155:337-338.
http://www.ncbi.nlm.nih.gov/pubmed/21893632
Hong-Xia W, Xiu-Mei L, Xiu-Hua H, Ya-Jun J, Gui-Hua Z, Wan-Chuan Z (2011) Clinical Significance of Tissue Factor and Vascular Endothelial Growth Factor Expressions on CD14+ Monocytes in Patients with Non Hodgkin Lymphoma. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 33:427-431.
http://www.ncbi.nlm.nih.gov/pubmed/21906453
Huang XX, Pang BS, Yang YH, Zhang HY, Guo SL (2011) [Change of coagulation functions and its significance in acute exacerbation of chronic obstructive pulmonary disease]. Zhonghua Yi Xue Za Zhi 91:1543-1545.
http://www.ncbi.nlm.nih.gov/pubmed/21914367
Ingerslev J, Sorensen B (2011) Parallel use of by-passing agents in haemophilia with inhibitors: a critical review. Br J Haematol.
http://www.ncbi.nlm.nih.gov/pubmed/21895627
Jenabali Jahromi B, Karimi M (2011) Long-term follow-up of prophylaxis with recombinant activated factor VII in patients with congenital factor VII deficiency. Haemophilia 17:713-715.
http://www.ncbi.nlm.nih.gov/pubmed/21299748
Jiang M, Wang Z, Yu Z, Bai X, Su J, Cao L, . . . Ruan C (2011) A novel missense mutation close to the charge-stabilizing system in a patient with congenital factor VII deficiency. Blood Coagul Fibrinolysis 22:264-270.
http://www.ncbi.nlm.nih.gov/pubmed/21372693
Jiang R, Wang NP, Tanaka KA, Levy JH, Guyton RA, Zhao ZQ, Vinten-Johansen J (2011) Factor Xa induces tissue factor expression in endothelial cells by P44/42 MAPK and NF-kappaB-dependent pathways. J Surg Res 169:319-327.
http://www.ncbi.nlm.nih.gov/pubmed/20451919
Kassel KM, Owens Iii AP, Rockwell CE, Sullivan BP, Wang R, Tawfik O, . . . Luyendyk JP (2011) Protease-Activated Receptor 1 and Hematopoietic Cell Tissue Factor Are Required for Hepatic Steatosis in Mice Fed a High-Fat Diet. Am J Pathol.
http://www.ncbi.nlm.nih.gov/pubmed/21907177
Kostovski E, Dahm AE, Iversen N, Hjeltnes N, Osterud B, Sandset PM, Iversen PO (2011) Melatonin stimulates release of tissue factor pathway inhibitor from the vascular endothelium. Blood Coagul Fibrinolysis 22:254-259.
http://www.ncbi.nlm.nih.gov/pubmed/21297449
Kresge N, Simoni RD, Hill RL (2011) Blood clotting and coagulation factors: the work of Yale Nemerson. 1980, 1982. J Biol Chem 286:e5-6.
http://www.ncbi.nlm.nih.gov/pubmed/21842549
Layland J, Ray MJ, Siresena T, Walters DL (2011) Increased expression of monocyte tissue factor and soluble CD40 ligand at mid-term follow-up following percutaneous coronary intervention. Blood Coagul Fibrinolysis 22:349-350.
http://www.ncbi.nlm.nih.gov/pubmed/21546798
Liu Y, Jiang P, Capkova K, Xue D, Ye L, Sinha SC, . . . Liu C (2011) Tissue Factor Activated Coagulation Cascade in The Tumor Microenvironment Is Critical For Tumor Progression And an Effective Target For Therapy. Cancer Res.
http://www.ncbi.nlm.nih.gov/pubmed/21880589
Masotti L, Di Napoli M, Godoy DA, Rafanelli D, Liumbruno G, Koumpouros N, . . . Prisco D (2011) The practical management of intracerebral hemorrhage associated with oral anticoagulant therapy. Int J Stroke 6:228-240.
http://www.ncbi.nlm.nih.gov/pubmed/21557810
Mirzaahmadi S, Asaadi-Tehrani G, Bandehpour M, Davoudi N, Tahmasbi L, Hosseinzadeh N, . . . Kazemi B (2011) Expression of Recombinant Human Coagulation Factor VII by the Lizard Leishmania Expression System. J Biomed Biotechnol 2011:873874.
http://www.ncbi.nlm.nih.gov/pubmed/21912483
Neufeld EJ, Kessler CM, Gill JC, Wilke CT, Cooper DL (2011) Exposure and safety of higher doses of recombinant factor VIIa >/=250 mug kg(-1) in individuals with congenital haemophilia complicated by alloantibody inhibitors: the Haemophilia and Thrombosis Research Society Registry experience (2004-2008). Haemophilia 17:650-656.
http://www.ncbi.nlm.nih.gov/pubmed/21299750
Newell-Caito JL, Laha M, Tharp AC, Creamer JI, Xu H, Maddur AA, . . . Bock PE (2011) Notecarin D binds human factor V and factor Va with high affinity in the absence of membranes. J Biol Chem.
http://www.ncbi.nlm.nih.gov/pubmed/21911491
Ogiwara K, Nogami K, Shima M (2011) Factor VIII activation by factor VIIa analog V158D/E296V/M298Q) in tissue factor-independent mechanisms. Thromb Haemost 106.
http://www.ncbi.nlm.nih.gov/pubmed/21901232
Phillips A (2011) Off-Label Use of Recombinant Factor VIIa. Ann Intern Med 155:337.
http://www.ncbi.nlm.nih.gov/pubmed/21893633
Piek CJ, Brinkhof B, Teske E, Rothuizen J, Dekker A, Penning LC (2011) High intravascular tissue factor expression in dogs with idiopathic immune-mediated haemolytic anaemia. Vet Immunol Immunopathol.
http://www.ncbi.nlm.nih.gov/pubmed/21899896
Sen P, Nayak R, Clark CA, Gopalakrishnan R, Esmon CT, Pendurthi UR, Rao LV (2011) Factor X binding to endothelial cell protein C receptor: comparison with factor VIIa and activated protein C. Blood 118:2635-2636.
http://www.ncbi.nlm.nih.gov/pubmed/21885613
Steiner T, Vincent C, Morris S, Davis S, Vallejo-Torres L, Christensen MC (2011) Neurosurgical outcomes after intracerebral hemorrhage: results of the Factor Seven for Acute Hemorrhagic Stroke Trial (FAST). J Stroke Cerebrovasc Dis 20:287-294.
http://www.ncbi.nlm.nih.gov/pubmed/20452785
Tiede A, Rand JH, Budde U, Ganser A, Federici AB (2011) How I treat the acquired von Willebrand syndrome. Blood 117:6777-6785.
http://www.ncbi.nlm.nih.gov/pubmed/21540459
Tong Y, Zhou J, Mao M, Gao J, Yuan L (2011) Generation of bioactive recombinant Ancylostoma caninum anticoagulant peptide c2. Protein Expr Purif.
http://www.ncbi.nlm.nih.gov/pubmed/21907287
Valentino LA, Cooper DL, Goldstein B (2011) Surgical experience with rFVIIa (NovoSeven) in congenital haemophilia A and B patients with inhibitors to factors VIII or IX. Haemophilia 17:579-589.
http://www.ncbi.nlm.nih.gov/pubmed/21294815
van den Berg YW, Reitsma PH (2011) Not Exclusively Tissue Factor: NETs Provide Another Link Between Chemotherapy and Thrombosis. J Thromb Haemost.
http://www.ncbi.nlm.nih.gov/pubmed/21910822
Van Dreden P, Woodhams B, Rousseau A, Favier M, Favier R (2011) Comparative evaluation of Tissue factor and Thrombomodulin activity changes during normal and idiopathic early and late foetal loss: The cause of hypercoagulability? Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/21880353
Winckers K, Siegerink B, Duckers C, Maurissen LM, Tans G, Castoldi E, . . . Rosendaal FR (2011) Increased Tissue Factor Pathway Inhibitor Activity is Associated with Myocardial Infarction in Young Women; Results From the Ratio Study. J Thromb Haemost.
http://www.ncbi.nlm.nih.gov/pubmed/21895962
Xu G, Wen H, Zhou H, Guo D, Zhou F, Chen D, . . . Wang H (2011) Involvement of IRAKs and TRAFs in anti-beta2GPI/ beta2GPI-induced tissue factor expression in THP-1 cells. Thromb Haemost 106.
http://www.ncbi.nlm.nih.gov/pubmed/21901230
Xu GY, Zhou H, Wen HP, Guo DL, Zhou F, Chen DD, Xie HX (2011) [Activation of tumor necrosis factor receptor-associated factor 6 in anti-beta2GPI/beta2GPI-induced tissue factor expression on THP-1 cells]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 27:487-490.
http://www.ncbi.nlm.nih.gov/pubmed/21557901
__________________________________________________________
TRIGGER is edited by Jim Morrissey and Pierre Neuenschwander, with editorial assistance by Genie Morrissey. It includes Abstracts of Papers in Press, Meeting Announcements, Positions Sought/Available,or any other pertinent item that subscribers may want to share with their colleagues. To submit an item for publication in Trigger, e-mail us. To request or cancel a subscription,or for more information about TRIGGER or the biology of tissue factor and factor VII, visit our web site. You can also contact us by mail: J.H. Morrissey, University of Illinois College of Medicine, 417 Med Sci Bldg MC-714, 506 S. Mathews Ave., Urbana, IL 61801, USA.
DISCLAIMER: TRIGGER is provided "as is" for information purposes only and without warranty of any kind, express or implied. Users shall assume the entire risk as to the accuracy and usefulness of information in TRIGGER. Opinions expressed here are not necessarily those of the editors or their employers. You may share TRIGGER with your scientific colleagues but you are not permitted to use it or its contents for commercial purposes.
__________________________________________________________
